Related Experiment Video

Updated: Dec 26, 2025

Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization
05:14

Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization

Published on: August 11, 2023

1.4K

Frequentist Analysis of Death Associated With Intravitreal Anti-Vascular Endothelial Growth Factor Therapy-Reply

Michele Reibaldi1, Matteo Fallico1,2, Gianni Virgili3,4

  • 1Department of Ophthalmology, University of Catania, Catania, Italy.

JAMA Ophthalmology
|March 13, 2020
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Demonstrating a Linear Relationship Between Vascular Endothelial Growth Factor and Luteinizing Hormone in Kidney Cortex Extracts
05:56

Demonstrating a Linear Relationship Between Vascular Endothelial Growth Factor and Luteinizing Hormone in Kidney Cortex Extracts

Published on: January 22, 2020

5.1K
Intravitreal Injections in the Ovine Eye
03:37

Intravitreal Injections in the Ovine Eye

Published on: July 5, 2022

3.8K

Related Experiment Videos

Last Updated: Dec 26, 2025

Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization
05:14

Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization

Published on: August 11, 2023

1.4K
Demonstrating a Linear Relationship Between Vascular Endothelial Growth Factor and Luteinizing Hormone in Kidney Cortex Extracts
05:56

Demonstrating a Linear Relationship Between Vascular Endothelial Growth Factor and Luteinizing Hormone in Kidney Cortex Extracts

Published on: January 22, 2020

5.1K
Intravitreal Injections in the Ovine Eye
03:37

Intravitreal Injections in the Ovine Eye

Published on: July 5, 2022

3.8K

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

896
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
896

Articles linked to this work by shared authors, journal, and citation graph.

Quantitative framework for synthesising defocus-curve evidence in simultaneous-vision intraocular lenses.

The British journal of ophthalmology·2026

Comparison of IOL Power Calculation Formulas After Sutureless Intrascleral One-Piece IOL Fixation: A Post-hoc Analysis.

Journal of refractive surgery (Thorofare, N.J. : 1995)·2026

AI Writing Vocabulary in Ophthalmology: Faster Non-Native Adoption, Unchanged Outcomes.

American journal of ophthalmology·2026

Do OCTA morphological patterns in neovascular AMD actually matter? A scoping review of clinical utility and terminological overlap.

Retina (Philadelphia, Pa.)·2026

Minimally invasive trabecular meshwork surgery for open-angle glaucoma.

The Cochrane database of systematic reviews·2026

Ketogenic diet as a therapeutic intervention for biochemical hyperandrogenism in PCOS women with obesity or overweight: a meta-analytic study.

Journal of endocrinological investigation·2026

Smartphone-Based 3D Ocular Reconstruction for Automated Quantitative Blepharoptosis Evaluation.

JAMA ophthalmology·2026

Ten-Year Update of a Global Survey of Corneal Transplant and Eye Banking.

JAMA ophthalmology·2026

Outcomes of As-Needed Aflibercept Treatment After Complete Regression in Polypoidal Choroidal Vasculopathy.

JAMA ophthalmology·2026

Why Metrics Matter in Thyroid Eye Disease: An Innovate TED Initiative.

JAMA ophthalmology·2026

Widening the Spectrum of Disease Expression due to Heterozygous Variants in EFEMP1.

JAMA ophthalmology·2026

Safety and Effects of Gildeuretinol Acetate on Retinal Atrophic Lesions in Stargardt Disease: The TEASE-1 Randomized Clinical Trial.

JAMA ophthalmology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us